Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Artigo em Inglês | MEDLINE | ID: mdl-24295101

RESUMO

The growing HIV burden on families and health systems is exerting a shift toward community caregivers, and is increasing the demand for functional community systems. In Uganda, where the number of people with HIV is increasing against a background of weak health systems, the role of community systems is poorly understood. We investigated the role of community systems in palliative care and the system elements required for an effective community response in Uganda. Qualitative interviews and focus group discussions were conducted among providers and recipients of palliative care, their family members, and governmental and community stakeholders in Mbale and Jinja, Uganda. Results showed that community systems play an important role in many aspects of palliative care--including personal, livelihood, nutritional and bereavement support--and often strengthen care linkages and referrals. For community systems to fulfill these roles effectively, multiple system elements--including leadership, training, partnerships, and enabling policies--are essential. Strengthening community systems could be an effective strategy to alleviate HIV burden on families and health systems. A systems approach could be a potent mechanism for determining which community structures to strengthen in order to maximize the impact of palliative care programs, and for guiding investments in HIV and health.


Assuntos
Fortalecimento Institucional/organização & administração , Serviços de Saúde Comunitária/organização & administração , Infecções por HIV/psicologia , Infecções por HIV/terapia , Cuidados Paliativos/organização & administração , Luto , Família , Infecções por HIV/mortalidade , Acessibilidade aos Serviços de Saúde/organização & administração , Humanos , Entrevistas como Assunto , Cuidados Paliativos/psicologia , Pesquisa Qualitativa , Apoio Social , Uganda
3.
PLoS One ; 13(5): e0197353, 2018.
Artigo em Inglês | MEDLINE | ID: mdl-29799833

RESUMO

Antimicrobials have been used in a prophylactic way to decrease the incidence of digestive disorders during the piglet post-weaning period. Nowadays, it is urgent to reduce their consumption in livestock to address the problem of antimicrobial resistance. In this study, the effect of a product on piglet microbiota has been investigated as an alternative to antimicrobials. Three groups of ten post-weaning pigs were sampled at 0, 15 and 30 days one week post-weaning; the control, antibiotic and feed additive group received a standard post-weaning diet without antibiotics or additives, the same diet as the control group but with amoxicillin and colistin sulphate and the same diet as the control group but with a feed additive (Sanacore-EN, Nutriad International N.V.), respectively. The total DNA extracted from faeces was used to amplify the 16S RNA gene for massive sequencing under manufacturer's conditions. Sequencing data was quality filtered and analyzed using QIIME software and suitable statistical methods. In general terms, age modifies significantly the microbiota of the piglets. Thus, the oldest the animal, the highest bacterial diversity observed for the control and the feed additive groups. However, this diversity was very similar in the antibiotic group throughout the trial. Interestingly, a clear increase in abundance of Bacillus and Lactobacillus spp was detected within the feed additive group versus the antibiotic and control groups. In conclusion, the feed additive group had a positive effect in the endogenous microbiota of post-weaning pigs increasing both, the diversity of bacterial families and the abundance of lactic acid bacteria during the post-weaning period.


Assuntos
Ração Animal , Anti-Infecciosos/farmacologia , Microbioma Gastrointestinal/efeitos dos fármacos , Microbioma Gastrointestinal/fisiologia , Suínos , Amoxicilina/farmacologia , Animais , Colistina/farmacologia , Diarreia/etiologia , Diarreia/veterinária , Fezes/microbiologia , RNA Ribossômico 16S/análise
4.
Lancet HIV ; 3(7): e323-32, 2016 07.
Artigo em Inglês | MEDLINE | ID: mdl-27365207

RESUMO

Although effective programmes are available and several countries have seen substantial declines in new HIV infections, progress in the reduction of adult HIV incidence has been slower than expected worldwide and many countries have not had large decreases in new infections in adults despite large reductions in paediatric infections. Reasons for slow progress include inadequate commitment, investment, focus, scale, and quality of implementation of prevention and treatment interventions. The UNAIDS-Lancet Commission on Defeating AIDS-Advancing Global Health reported that the provision of large-scale, effective HIV prevention programmes has failed and called on stakeholders to "get serious about HIV prevention". An ambitious worldwide target has been set by UNAIDS to reduce new infections below 500 000 by 2020-a 75% reduction from 2010. Models show that such a reduction requires a combination of primary prevention interventions and preventative effects of treatment. Achievement of the target will require more effective delivery of HIV prevention for sufficient coverage in populations at greatest risk of infection ensuring that interventions that have proved effective are made available, barriers to their uptake are overcome, demand is created, and use is consistent and occurs at the right scale with high coverage. This paper discusses how programmatic targets for prevention in a worldwide plan could be used to re-energise the HIV prevention approach. A management framework is proposed outlining global, regional, national, and subnational actions and is summarised in a call for action on HIV prevention for 2020.


Assuntos
Síndrome da Imunodeficiência Adquirida/prevenção & controle , Atenção à Saúde , Gerenciamento Clínico , Infecções por HIV/prevenção & controle , Síndrome da Imunodeficiência Adquirida/virologia , Adulto , Países em Desenvolvimento/estatística & dados numéricos , Feminino , Saúde Global , Infecções por HIV/virologia , Humanos , Incidência
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA